| Mifeprex (mifepristone) / Danco Laboratories |
NCT00881140: Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids |
|
|
| Completed | 2a | 30 | RoW | mifepristone vaginal tablets, mifepristone | BioPro Medical Ltd | Uterine Fibroid, Vaginal Bleeding. | 05/12 | 07/12 | | |
|
NCT00352911: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects |
|
|
| Completed | 2 | 19 | US | VGX-410 (Mifepristone), Mifeprex, Placebo for VGX-410 (Mifepristone) | VGX Pharmaceuticals, LLC | HIV Infections | 06/07 | 11/07 | | |
NCT00255177: Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients |
|
|
| Completed | 2 | 44 | US | VGX-410 (Mifepristone), Mifepristone, Placebo | VGX Pharmaceuticals, LLC | Hepatitis C Virus Infection | 09/07 | 01/08 | | |
NCT00422201 / 2006-004679-36: Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion |
|
|
| Terminated | 2 | 18 | Europe, US | Mifepristone | HRA Pharma | Cushing's Syndrome | 04/12 | 04/12 | | |
2019-002032-84: Evaluating the effect of a drug that at full-term preganacy, softens the neck of the womb ready for delivery Hodnocení účinku přípravku, který v období dosažení termínu porodu změkčuje hrdlo dělohy připravené na porod |
|
|
| Not yet recruiting | 2 | 150 | RoW | Mifepristone 150, Mifepristone 75, Tablet | Disphar International B.V, Disphar International B.V. | Full-term pregnancy women at week 40 + 5 of gestation with intact membranes, the first delivery, singleton physiological pregnancy těhotné ženy po dosažení termínu porodu ve stadiu týden 40 + 5 s intaktními membránami, prvorodičky, jednočetné fyziologické těhotenství, pregnant women at week 40 + 5 days of pregnancy giving birth for the first time, singleton (one fetus) pregnancy without medical complications těhotné ženy ve stadiu těhotenství 40 týdnů + 5 dní, první porod, jednočetné těhotenství bez zdravotních komplikací, Body processes [G] - Reproductive physiologi cal processes [G08] | | | | |
RESET-m, NCT05217758: edication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma |
|
|
| Recruiting | 2 | 158 | Europe | Mifepristone, Placebo | VU University Medical Center, Netherlands Brain Foundation, Corcept Therapeutics | Major Depressive Disorder, Childhood Trauma | 12/23 | 06/24 | | |
TBCRC 058, NCT06099769: A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
|
|
| Recruiting | 2 | 201 | US | Enzalutamide, Mifepristone, TPC | Memorial Sloan Kettering Cancer Center, Astellas Pharma US, Inc., Breast Cancer Research Foundation, Corcept Therapeutics | Metastatic Breast Cancer | 10/27 | 10/27 | | |
NCT00721201: Glucocorticoid Receptor Antagonism in Subclinical Cushings |
|
|
| Completed | 1/2 | 6 | Europe | Mifepristone | Sheffield Teaching Hospitals NHS Foundation Trust, HRA Pharma | Subclinical Cushing's | 03/10 | 03/10 | | |
